|
|
|
Taglich's Company Profile
for: |
|
|
|
Most Recent Update |
|
Updated
Earnings Note (Dated November 6, 2008) |
|
What's New |
|
New information will be posted soon... |
|
Company Description |
NeoGenomics, Inc. (NGNM.OB) operates high complexity clinical laboratories performing specialized, high-value genetic tests used in the diagnosis and prognosis of cancer. The company, which began operations in 2002, is headquartered in Fort Myers, FL, and also operates laboratories in Nashville, TN and Irvine, CA. The company’s facilities are licensed under all relevant Federal and state laws, and its services qualify for reimbursement under major government insurance programs, principally Medicare and Medicaid.
Genetic testing, distinct from the larger clinical laboratory and anatomic testing segments of the market, analyzes chromosomes, genes and DNA, seeking abnormalities that confirm cancer diagnoses. Genetic testing, the fastest growing segment of the clinical testing market, is characterized by high-cost (and high margin) tests. The company also operates a contract research organization. The company’s facilities are licensed under all relevant Federal and state laws, and its services qualify for reimbursement under major government insurance programs, principally Medicare and Medicaid. |
|
Taglich Research Reports |
Initial
Research Report (Dated August 4, 2008)
All Research Reports are in Adobe Acrobat format.
(for the latest Adobe Acrobat reader click
here)
* The information and
statistical data contained herein have been obtained from
sources, which we believe to be reliable but in no way are
warranted by us as to accuracy or completeness. We do not
undertake to advise you as to changes in figures or our views.
This is not a solicitation of any order to buy or sell. Taglich
Brothers, Inc. is fully disclosed with its clearing firm,
Pershing, LLC, is not a market maker and does not sell to or buy
from customers on a principal basis. The above statements are
the opinion of Taglich Brothers, Inc. and are not a guarantee
that the target price for the stock will be met or that
predicted business results for the company will occur. There may
be instances when fundamental, technical and quantitative
opinions contained in the reports are not in concert. We, our
affiliates, any officer, director or stockholder or any member
of their families may from time to time purchase or sell any of
the above-mentioned or related securities. Analysts and members
of the Research Department are prohibited from buying or selling
securities issued by the companies that Taglich Brothers, Inc.
has a research relationship with, except if ownership of such
securities was prior to the start of such relationship, then an
Analyst or member of the Research Department may sell such
securities after obtaining expressed written permission from the
Director of Research. As of the date of this report, no officers
or employees of Taglich Brothers, Inc. owned any of the
company’s shares. All research issued by Taglich Brothers, Inc.
is based on public information. Taglich Brothers, Inc. does not
currently have an Investment Banking relationship with the
company mentioned and was not a manager or co-manager of any
offering for the company within the last three years. All
research issued by Taglich Brothers, Inc. is based on public
information. In June, 2008, the company paid a monetary fee of
US$6,000, representing payment for the first three of 12 months,
for the creation and dissemination of research reports. From
October, 2008 through June, 2009, the company will pay a monthly
monetary fee of US$2,000, for a total one-year fee of US$24,000
for the creation and dissemination of research reports. For
further information and Taglich Brothers, Inc. ownership data
please refer to each individual report. |
|
Send this Page to a friend |
|
To send this page to a friend, just fill out the form below and press
the "send it" button!
|
|
|
Taglich Covered Companies |
AeroCentury Corp.
Anglo Swiss Resources, Inc.
BioForce Nanosci. Holdings, Inc.
Carbiz, Inc.
Cardium Therapeutics, Inc.
Command Security Corp.
CTI Industries Corp
Derma Sciences, Inc.
DRI Corporation
EnerLume Energy Mgt. Corp.
GammaCan International, Inc.
Hartmarx Corporation
Hyperdynamics Corporation
INX, Inc.
Life Partners Holdings, Inc.
Lifeway Foods, Inc.
Littlefield Corporation
Micro Imaging Tech, Inc.
NeoGenomics, Inc.
Orchids Paper Products
Park City Group, Inc.
Pressure BioSciences, Inc.
Radiant Logistics, Inc.
Reed's Inc.
Salon Media Group, Inc.
Simulations Plus, Inc.
SMF Energy Corporation
TranSwitch Corporation
UFP Technologies, Inc.
US 1 Industries, Inc.
Wave Systems Corp.
Williams Controls, Inc.
|
|